Repeated administration of the dopaminergic agonist apomorphine: development of apomorphine aggressiveness and changes in the interaction between dopamine D(2) receptors and G-proteins.
Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 6
Abstract
The repeated administration of dopamine receptor agonists produces a progressive increase in the acute behavioral effects of these drugs, known as behavioral sensitization. These includes the development of impulsive aggressive behavior after repeated small doses of apomorphine. The aim of this investigation was to study the behavioral specificity of the apomorphine-induced aggressiveness model and its possible relationship with changes in the D(2) receptor-G-protein interaction. Apomorphine (1 mg/kg, sc) was administered daily for three weeks to two groups of male Wistar rats. One of the groups was repeatedly tested for the development of aggressiveness. Apomorphine aggressiveness developed stepwise with repeated behavioral testing. Neither apomorphine-treated group displayed any behavioral change in the open field test, forced swimming test, or quipazine-induced wet-dog shake response test. Three weeks of apomorphine administration in the home cage increased the GDP binding affinity and reduced the [(35)S]GTPgammaS binding in striatal membranes, but this effect was not present in apomorphine-treated rats that had developed aggressiveness. In conclusion, sensitization to apomorphine, as measured by the expression of aggressiveness, developed only with accumulating apomorphine-induced fighting, was behaviorally specific, and appeared to be dependent on the D(2) receptor-G-protein interaction. The absence of sensitization to the dopaminergic stimulation may be mediated by the downregulation of D(2) receptor sensitivity via changes in the GDP affinity of G-proteins.
Authors and Affiliations
Ruth Rudissaar, Jaanus Harro, Katrin Pruus, Ago Rinken, Lembit Allikmets
N-methylnicotinamide failed to induce endothelial prostacyclin release in perfused rat hindquarters.
N-methylnicotinamide, a nicotinamide derivative, possesses anti-thrombotic activity, although the mechanism of its action is unclear. Using a rat model of isolated perfused hindlimb, we tested whether this metabolite of...
Differential effects of glycine on the anticonvulsant activity of D-cycloserine and L-701,324 in mice.
The anticonvulsant effects of D-cycloserine, which is a partial agonist of the glycine/N-methyl-D-aspartate (NMDA) receptor, and L-701,324, which is a selective and potent antagonist that acts at the glycine site, were s...
Protoporphyrin IX induces apoptosis in HeLa cells prior to photodynamic treatment.
Photodynamic therapy (PDT) combining treatment with a light-excited compound and laser light induction, via cellular ROS generation, kills cancer cells by damaging organelles and impairing metabolic pathways. As the exac...
Physiology and pharmacology of melatonin in relation to biological rhythms.
Melatonin is an evolutionarily conserved molecule that serves a time-keeping function in various species. In vertebrates, melatonin is produced predominantly by the pineal gland with a marked circadian rhythm that is gov...
Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
Several clinical reports have postulated a beneficial effect of the addition of a low dose of risperidone to the ongoing treatment with antidepressants in treatment-resistant depression.